You are here

  • Home
  • Archive
  • Volume 11, Issue Suppl 2
  • 1147-H Novel immunotherapy regiment approach for pancreatic ductal adenocarcinoma (PDCA) using human MUC1 transgenic mice (MUC1.tg) model: optimizing conditions for MVA vaccine evaluation

Article metrics

Article menu

Download PDFPDF

Regular Abstracts – Part 2
Immune-Stimulants and Immune Modulators
1147-H Novel immunotherapy regiment approach for pancreatic ductal adenocarcinoma (PDCA) using human MUC1 transgenic mice (MUC1.tg) model: optimizing conditions for MVA vaccine evaluation

 

Online download statistics by month:

Online download statistics by month: December 2023 to June 2025

AbstractFullPdf
Dec 20232401
Jan 20243203
Feb 20242202
Mar 20241500
Apr 20241200
May 20242600
Jun 20244000
Jul 20243002
Aug 2024200
Sep 20242501
Oct 2024807
Nov 20243205
Dec 202416010
Jan 20251606
Feb 2025005
Mar 2025101
Apr 2025002
May 2025003
Jun 2025204
Total303052